The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-855

Wow this thread has almost hit 200,000 views ,,

Tight Hands required now , Management need to push the News Hard to get the value runs on the board ,,, MC is still low in comparison to the sector
PAA has climbed significantly to lift us to the 56th highest valued MC Biotech over the past 7 months from slot 118 in the Sector..

The heavy drop back from 53.5c to 26c seemed unwarranted , IMHO had we had supportive media to propel PAA upward we could have seen 70c

The next Catalyst of Supplying the FDA with the Supportive information (Phase I/II Data) to enable the processing of the Orphan Drug Designation application will stimulate another round of FOMO and bring on board more Investors and deliver greater demand for PAA Shares..

Being around 50c again for when the Announcement drops,, that PAA have been awarded FDA Orphan Drug Designation should give us another 20% gain so best we have that delivered rom a strong base of 50c plus...